期刊文献+

环氧合酶2抑制剂的抗胰腺癌作用及相关机制 被引量:2

Anti-tumor effect and mechanism of cyclooxygenase 2 inhibitor in pancreatic cancer
下载PDF
导出
摘要 目的探讨环氧合酶2(COX-2)抑制剂对胰腺癌细胞增殖、侵袭、迁移能力和对COX-2、基质金属蛋白酶(MMP)-14蛋白表达的影响以及可能的抗胰腺癌机制。方法不同浓度的COX-2抑制剂塞来昔布(20、60、100μmol/L)处理胰腺癌细胞后,用MTT比色法检测细胞的增殖能力;用Transwell侵袭实验和划痕实验检测细胞的侵袭能力和迁移能力;ELISA检测MMP-14和COX-2的蛋白表达情况。结果 MTT增殖实验、Transwell侵袭实验、划痕实验分别提示,COX-2抑制剂作用后胰腺癌细胞的增殖、侵袭、迁移能力均以浓度梯度形式下降(P<0.05);ELISA结果显示,胰腺癌细胞中COX-2和MMP-14的蛋白表达水平相应降低(P<0.05),两者表达具有显著正相关性(r=0.873,P<0.05)。结论 COX-2抑制剂可能通过抑制COX-2表达下调MMP-14表达,进而以浓度梯度形式减弱胰腺癌细胞的增殖、侵袭、迁移能力,起到抗胰腺癌作用。 Objective To investigate the effect of COX-2 inhibitor on proliferation, migration, invasion and the expression of COX-2, matrix metalloproteinase (MMP) -14 in pancreatic cancer cell and its possible anti-tumor mechanism. Methods Human pancreatic cancer cell line PANC-1 was treated with diverse concentrations of COX-2 inhibitor celebrex (20, 60, 100μmol/L). Cell proliferation, invasion and migration capabilities were measured by MTT colorimetry, Transwell invasion assay, and scratch assay. The protein expression of COX-2 and MMP-14 was assessed by ELISA. Results The proliferation, invasion and migration capabilities were decreased in a concentration-dependent manner by COX-2 inhibitor (P 〈 0.05 ). The protein expression of COX-2 and MMP-14 was correspondingly reduced ( P 〈 0. 05 ). MMP-14 expression was positively correlated with COX-2 expression ( r =0. 873 ,P 〈 0. 01 ). Conclusion COX-2 inhibitor may down-regulate MMP-14 expression via inhibiting COX-2 expression, then attenuating the proliferation, invasion and migration of human pancreatic cancer cell in a concentration-dependent manner, contributing to its anti-tumor effect in pancreatic cancer.
出处 《解剖学报》 CAS CSCD 北大核心 2015年第1期81-84,共4页 Acta Anatomica Sinica
基金 新疆生产建设兵团国际合作基金资助项目(2011BC005) 新疆研究生科研创新项目(XJGRI2014063)
关键词 胰腺癌 环氧合酶2抑制剂 基质金属蛋白酶14 侵袭 迁移 四甲基偶氮唑盐法 Pancreatic cancer Cyclooxygenase 2 inhibitor Matrix metalloproteinase 14 Invasion Migration Methyl thiazolyl tetrazolium method Human
  • 相关文献

参考文献12

  • 1Pahwa S, Stawikowski MJ, Fields GB. Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression[J]. Cancers, 2014,6( 1 ) :416-435.
  • 2Poincloux R, Lizarraga F, Chavrier P. Matrix invasion by tumnur cells: a focus on MTI-MMP trafficking to invadopodia[ J]. J Cell Sci, 2009,122( Pt 17 ) :3015-3024.
  • 3Hu M, Peluffo G, Chen H, et al. Role of COX-2 in epithelial- stromal cell interactions and progression of ductal carcinoma in situ of the breast[J]. Proc Nail Acad Sci USA, 2009,106(9) :3372-3377.
  • 4Mihaljevie AL, Miehalski CW, Friess It, et al. Molecular nlechanism of pancreatic cancer understanding proliferation, invasion, and metastasis[J]. Langenbecks Arch Surg, 2010,395 (4) :295-308.
  • 5Vosooghi M, Amini M. The discovery and development of cyelooxygenase-2 inhibitors as potential anticaneer therapies [ J ]. Expert Opin Drug D iscov, 2014,9 (3) :255-267.
  • 6Annabi B, Laflamme C, Sina A, et al. A MTI-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133 + U87 glioblastoma cells[ J]. J Neuroinflmnmation, 2009,6 (8): 1186-1196.
  • 7Sadeghi-Aliabadi H, Aliasgharluo M, Fattahi A, et al. In vitro cytotoxic evaluation of some synthesized COX-2 inhibitor derivatives against a panel of human cancer cell lines [ J]. Res Pharm Sci, 2013,8(4) :298-303.
  • 8Haage A, Nam DH, Ge X, et al. Matrix met alloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasima [J]. Biochem Biophys Res Commun, 2014, 450(1) :213-218.
  • 9Ding N, Cut XX, Gao Z, et al. A triple combination of atorvastatin, Celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors [ J ]. Itat J Dnc,d, 2014,44(6) :2139-2145.
  • 10Chen WQ, Liang D, Zhang SW, et al. Pancreatic cancer incidence and mortality patterns in china, 2009 [ J ]. Asian Pac J Cancer Prey, 2013,14(12) :7321-7324.

同被引文献13

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部